3809 |
Best Practice Under Consideration of the Possible Etiologic Factors and Mechanisms to Prevent RTAD After TEVAR |
Toshihisa Asakura |
Apr. 27. 19 |
3808 |
Case 2: Rotational Atherectomy for Severely Calcified Lesions |
Si-Hyuck Kang |
Apr. 27. 19 |
3807 |
Type 2 Endoleaks Should Be Treated |
Ho Jong Chun |
Apr. 27. 19 |
3806 |
Long-term Results from the IN.PACT SFA DCB Clinical Trial: Continued Efficacy, Continued Safety |
Fabrizio Fanelli |
Apr. 27. 19 |
3805 |
The Odyssey of TAVR from Concept to Clinical Reality |
Alain G. Cribier |
Apr. 27. 19 |
3804 |
Case 1: eCPR - Complex PCI for Patients with Low EF |
James Flaherty |
Apr. 27. 19 |
3803 |
Cerebral Protection in TAVR: Which Patient Category or Anatomical Subset? |
Eberhard Grube |
Apr. 27. 19 |
3802 |
Role of External Stents for SVG in 2019: Update for Cardiologists |
David Paul Taggart |
Apr. 27. 19 |
3801 |
AAA Graft: Current Status and Future Perspectives |
Woong Chol Kang |
Apr. 27. 19 |
3800 |
Chimney Technique for Juxtarenal AAA: Delicate |
Gi-Young Ko |
Apr. 27. 19 |